Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $3,342 | $4,251 | $3,922 | $3,965 | $3,793 |
| Gross Profit | $1,657 | $2,361 | $2,127 | $2,086 | $1,958 |
| Operating Income | -$12 | $622 | -$937 | -$85 | -$879 |
| Net Income | -$83 | $421 | -$950 | -$132 | -$910 |
Over the five-year period, DENTSPLY SIRONA Inc.’s revenue grew from USD 3,342 million in 2020 to a peak of USD 4,251 million in 2021 before gradually declining to USD 3,793 million in 2024. This trend is mirrored in gross profit, which increased from USD 1,657 million in 2020 to USD 2,361 million in 2021 and then tapered off to USD 1,958 million by 2024. The significant year-over-year growth between 2020 and 2021—approximately a 27% rise in revenue coupled with similar gains in gross profit—suggests that the company may have benefited from recovering market demand and operational efficiencies during that period. In stark contrast, operating income and net income performance were notably volatile. After recording a slight operating loss (USD -12 million) and net loss (USD -83 million) in 2020, the company posted strong positive figures in 2021, with operating income of USD 622 million and net income of USD 421 million. However, the turnaround was short-lived, as operating income plunged by over 200% to a loss of USD 937 million in 2022, and net income declined sharply to a loss of USD 950 million, trends that persisted in subsequent years. Such swings exceeding 20% year-over-year indicate significant operational disruptions or shifts in cost structure. Overall, while the revenue and gross profit margins demonstrate the company’s underlying ability to generate sales, the recurring losses in operating and net income raise concerns about its current operational dynamics and sustainability. These metrics suggest that while DENTSPLY SIRONA retains market presence in the competitive dental and oral healthcare industry, addressing operational inefficiencies and managing costs will be critical for its sustained financial health.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.